Cardiac computed tomography-derived myocardial tissue characterization after anthracycline treatment.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
06 2022
Historique:
revised: 24 01 2022
received: 26 10 2021
accepted: 17 02 2022
pubmed: 16 3 2022
medline: 6 5 2022
entrez: 15 3 2022
Statut: ppublish

Résumé

Understanding cardiac function after anthracycline administration is very important from the perspective of preventing the onset of heart failure. Although cardiac magnetic resonance and echocardiography are recognized as the 'gold standard' for detecting cardiotoxicity, they have many shortcomings. We aimed to investigate whether cardiac computed tomography (CCT) could replace these techniques, assessing serial changes in cardiac tissue characteristics as determined by CCT after anthracycline administration. We prospectively investigated 15 consecutive breast cancer patients who were scheduled to receive anthracycline therapy. We performed echocardiography and CCT before and 3, 6, and 12 months after anthracycline treatment. The mean cumulative administered anthracycline dose was 269.9 ± 14.6 mg/m Our findings indicated that CCT could provide adequate information about the characteristics of myocardial tissue after anthracycline administration. CCT may improve the understanding of cardiotoxicity by compensating for the weaknesses of echocardiography. This technique could be useful for understanding cardiac tissue characterization as a 'one-stop shop' evaluation, providing new insight into cardiooncology.

Identifiants

pubmed: 35289088
doi: 10.1002/ehf2.13867
pmc: PMC9065838
doi:

Substances chimiques

Anthracyclines 0
Antibiotics, Antineoplastic 0

Banques de données

UMIN-CTR
['UMIN000047554']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1792-1800

Informations de copyright

© 2022 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

J Cardiol Cases. 2018 May 31;18(3):88-91
pubmed: 30279919
Circ J. 2021 Mar 25;85(4):393-396
pubmed: 33597324
Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):290-300
pubmed: 29211884
J Hypertens. 2019 Apr;37(4):754-764
pubmed: 30817457
Circ J. 2012;76(11):2623-32
pubmed: 22813873
Eur Heart J. 2012 Jul;33(14):1787-847
pubmed: 22611136
Emerg Radiol. 2019 Feb;26(1):109-112
pubmed: 29732519
J Am Soc Echocardiogr. 2012 Nov;25(11):1141-52
pubmed: 23000452
Eur Heart J Case Rep. 2020 Nov 12;4(6):1-5
pubmed: 33442607
Am J Hypertens. 2019 Oct 16;32(11):1082-1090
pubmed: 31271191
Circ J. 2019 Jun 25;83(7):1613
pubmed: 30568048
J Cardiovasc Magn Reson. 2008 Jan 22;10:5
pubmed: 18272009
Eur Heart J Case Rep. 2020 Jul 28;4(4):1-2
pubmed: 32974442
Int J Cardiol Heart Vasc. 2021 Jun 04;34:100806
pubmed: 34141861
Eur Heart J Cardiovasc Imaging. 2021 Mar 22;22(4):397-405
pubmed: 33555007
J Clin Oncol. 2017 Mar 10;35(8):893-911
pubmed: 27918725
Medicine (Baltimore). 2019 Nov;98(44):e17602
pubmed: 31689764
Eur Radiol. 2020 Feb;30(2):691-701
pubmed: 31471751
Ann Oncol. 2020 Feb;31(2):171-190
pubmed: 31959335
Eur Heart J. 2016 Sep 21;37(36):2768-2801
pubmed: 27567406
Eur Heart J. 2014 Mar;35(10):612-23
pubmed: 23666251
Eur J Heart Fail. 2020 Sep;22(9):1504-1524
pubmed: 32621569
Am J Cardiol. 2013 Mar 1;111(5):717-22
pubmed: 23228924
ESC Heart Fail. 2022 Jun;9(3):1792-1800
pubmed: 35289088
Int J Cardiol Heart Vasc. 2021 May 18;34:100797
pubmed: 34041357
J Am Soc Echocardiogr. 2014 Sep;27(9):911-39
pubmed: 25172399
Eur Heart J. 2012 May;33(10):1268-78
pubmed: 22279111
Medicine (Baltimore). 2019 Sep;98(38):e17069
pubmed: 31567942
Acad Radiol. 2021 May;28(5):e119-e126
pubmed: 32402786
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
Open Heart. 2021 Apr;8(1):
pubmed: 33863836
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
Eur J Heart Fail. 2020 Nov;22(11):1945-1960
pubmed: 32463967
J Am Coll Cardiol. 2015 Jun 30;65(25):2739-46
pubmed: 26112199

Auteurs

Koichi Egashira (K)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Daisuke Sueta (D)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Masafumi Kidoh (M)

Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Mai Tomiguchi (M)

Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Seitaro Oda (S)

Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Hiroki Usuku (H)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.

Kaori Hidaka (K)

Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Lisa Goto-Yamaguchi (L)

Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Aiko Sueta (A)

Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Takashi Komorita (T)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Fumi Oike (F)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Koichiro Fujisue (K)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Eiichiro Yamamoto (E)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Shinsuke Hanatani (S)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Seiji Takashio (S)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Satoshi Araki (S)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Kenichi Matsushita (K)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.
Division of Advanced Cardiovascular Therapeutics, Kumamoto University Hospital, Kumamoto, Japan.

Yutaka Yamamoto (Y)

Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Toshinori Hirai (T)

Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.

Kenichi Tsujita (K)

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto, 860-8556, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH